M. Zagula

The new topical ascomycin derivative SDZ ASM 981 does not induce skin atrophy when applied to normal skin for 4 weeks: a randomized, double‐blind controlled study

J. Ortonne, C. Paul, L. Duteil, 2001, The British journal of dermatology.

Green care in Wrocław hospital gardens

K. Sobiech, M. Zagula, K. Adamczyk, 2013 .

Pilot study of terbinafine in children suffering from tinea capitis: evaluation of efficacy, safety and pharmacokinetics

M. Zagula, H. Humbert, H. Lakhdar, 1995, The British journal of dermatology.

Comparative multicentre double-blind study of terbinafine (250 mg per day) versus griseofulvin (1 g per day) in the treatment of dermatophyte onychomycosis

L. Dubertret, J. Bonnetblanc, Y. Prost, 1997 .